Sham (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 211 | 左心低形成症候群 | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04181255 (ClinicalTrials.gov) | February 25, 2020 | 26/11/2019 | Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy | The Cold Heart Study: A Randomized Pilot Trial of Surfactant Therapy Following Deep Hypothermic Circulatory Arrest During Cardiac Surgery | Congenital Heart Disease;Hypoplastic Left Heart Syndrome | Drug: Curosurf;Drug: Sham | University of Michigan | Chiesi Farmaceutici S.p.A. | Recruiting | N/A | 12 Weeks | All | 60 | Phase 1 | United States |